Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESMERALDA: Eribulin and Bevacizumab in HER2- Metastatic Breast Cancer
NCT01941407Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Nov 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by ARCAGY. Started Nov 2013; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01941407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941407.